Literature DB >> 11893685

Linkage analysis in a large family with primary pulmonary hypertension: genetic heterogeneity and a second primary pulmonary hypertension locus on 2q31-32.

Bart Janssen1, Matthias Rindermann, Ulrike Barth, Gabriel Miltenberger-Miltenyi, Derliz Mereles, Adel Abushi, Werner Seeger, Wolfgang Kübler, Claus R Bartram, Ekkehard Grünig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11893685     DOI： 10.1378/chest.121.3_suppl.54s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  5 in total

Review 1.  [Pulmonary hypertension. Pathophysiology and current concepts of medication therapy].

Authors:  H Wilkens
Journal:  Anaesthesist       Date:  2004-08       Impact factor: 1.041

Review 2.  Pulmonary capillary haemangiomatosis in children and adolescents: report of a new case and a review of the literature.

Authors:  Katalin Bartyik; Olga Bede; Laszlo Tiszlavicz; Beata Onozo; Istvan Virag; Sandor Turi
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

Review 3.  Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications.

Authors:  E D Burg; C V Remillard; J X-J Yuan
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

Review 4.  Genetics and genomics of pulmonary arterial hypertension.

Authors:  Rajiv D Machado; Oliver Eickelberg; C Gregory Elliott; Mark W Geraci; Masayuki Hanaoka; James E Loyd; John H Newman; John A Phillips; Florent Soubrier; Richard C Trembath; Wendy K Chung
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

5.  Identification of a new intronic BMPR2-mutation and early diagnosis of heritable pulmonary arterial hypertension in a large family with mean clinical follow-up of 12 years.

Authors:  Katrin Hinderhofer; Christine Fischer; Nicole Pfarr; Justyna Szamalek-Hoegel; Mona Lichtblau; Christian Nagel; Benjamin Egenlauf; Nicola Ehlken; Ekkehard Grünig
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.